Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
346
-
Total 13F shares, excl. options
-
73.4M
-
Shares change
-
+134K
-
Total reported value, excl. options
-
$7.18B
-
Value change
-
-$46.3M
-
Put/Call ratio
-
1.32
-
Number of buys
-
164
-
Number of sells
-
-192
-
Price
-
$97.82
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2020
461 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2020.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 346 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.4M shares
of 106M outstanding shares and own 69.5% of the company stock.
Largest 10 shareholders include FMR LLC (7.41M shares), VANGUARD GROUP INC (6.54M shares), BlackRock Inc. (4.89M shares), SANDS CAPITAL MANAGEMENT, LLC (4.4M shares), Capital Research Global Investors (3.87M shares), JANUS HENDERSON GROUP PLC (3.52M shares), STATE STREET CORP (2.05M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.03M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.69M shares), and AMERIPRISE FINANCIAL INC (1.61M shares).
This table shows the top 346 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.